Leslie R. Boyd
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Leslie R. Boyd has a total of 225 co-authors. Here are the top co-authors by number of shared publications:
- John Patrick Curtin
NYU, Sch Med, New York, NY USA
32 shared publications - Bhavana Pothuri
Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, New York University Grossman School of Medicine, United States
28 shared publications - Franco M. Muggia
Division of Medical Oncology, Department of Medicine, New York University, New York, NY, USA
13 shared publications J. Lee
NYU, Sch Med, New York, NY USA
12 shared publications- Akiva Pesach Novetsky
Westchester Medical Center/New York Medical College
7 shared publications J.Y. Chern
Univ S Florida, Tampa, FL 33620 USA
7 shared publications
Latest Publications
- Open Access
- 1 March 2025
- Published by Elsevier in Gynecologic Oncology Reports
- Vol. 58, 101713
The effect of isolated tumor cells on adjuvant treatment decisions for patients with endometrial cancer: A retrospective case series
- 1 March 2025
- Published by Elsevier in Gynecologic Oncology Reports
- Vol. 58, 101713
Open AccessThe effect of isolated tumor cells on adjuvant treatment decisions for patients with endometrial cancer: A retrospective case series
- Open Access
- 10 May 2022
- Published by Elsevier in Gynecologic Oncology Reports
- Vol. 41, 100997
The impact of the ban on elective surgery in New York City during the coronavirus outbreak on gynecologic oncology patient care
- 10 May 2022
- Published by Elsevier in Gynecologic Oncology Reports
- Vol. 41, 100997
Open AccessThe impact of the ban on elective surgery in New York City during the coronavirus outbreak on gynecologic oncology patient care
- Open Access
- 20 September 2021
- Published by Elsevier in Gynecologic Oncology Reports
- Vol. 38, 100862
Enhanced recovery Pathways in gynecologic surgery: Are they safe and effective in the elderly?
- 20 September 2021
- Published by Elsevier in Gynecologic Oncology Reports
- Vol. 38, 100862
Open AccessEnhanced recovery Pathways in gynecologic surgery: Are they safe and effective in the elderly?
- 1 September 2021
- Published by Elsevier in Gynecologic Oncology
- Vol. 162 (3) , 529-531
The oncology care model and the future of alternative payment models: A gynecologic oncology perspective
- 1 September 2021
- Published by Elsevier in Gynecologic Oncology
- Vol. 162 (3) , 529-531
The oncology care model and the future of alternative payment models: A gynecologic oncology perspective
- 1 August 2021
- Published by Elsevier in Gynecologic Oncology
- Vol. 162, S101
Can we talk? The association between language and preoperative wait times for gynecologic oncologic patients
- 1 August 2021
- Published by Elsevier in Gynecologic Oncology
- Vol. 162, S101
Can we talk? The association between language and preoperative wait times for gynecologic oncologic patients
- 1 January 2021
- Published by MRE Press in European Journal of Gynaecological Oncology
- Vol. 42 (6) , 1099-1104
Give me a break: oncologists’ perception of systemic treatment holidays
- 1 January 2021
- Published by MRE Press in European Journal of Gynaecological Oncology
- Vol. 42 (6) , 1099-1104
Give me a break: oncologists’ perception of systemic treatment holidays
- 1 June 2020
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 30 (6) , 735-743
Prognostic significance of lymphovascular space invasion for stage IA1 and IA2 cervical cancer
Background Data regarding the prognostic significance of lymphovascular space invasion (LVSI) for stage IA1 and IA2 cervical cancer are limited. Specifically, the role of LVSI as an independent risk factor for mortality in stage IA disease has not been shown. Objective We examined the association between LVSI and nodal metastases and survival for women with stage IA1 and IA2 cervical cancer. Study Design We used the National Cancer Database to identify patients with stage IA adenocarcinoma or squamous carcinoma of the cervix from January 2010 through December 2015 for whom LVSI status was known. Mixed-effect log-Poisson models were used to identify predictors of LVSI. Cox proportional hazard models and Kaplan-Meier curves were used to compare all-cause mortality. Results We identified 3239 patients with stage IA1 and 1049 patients with stage IA2 carcinoma of the cervix. Among patients with stage IA1 and IA2 disease, 10.5% and 18.8% had LVSI, respectively. Less than 1% of patients with stage IA1 disease without LVSI had positive nodes compared with 7.8% of those with LVSI (pConclusions LVSI is associated with lymph node metastases in patients with stage IA cervical cancer. LVSI is associated with decreased survival for women with stage IA2 cervical cancer.
- 1 June 2020
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 30 (6) , 735-743
Prognostic significance of lymphovascular space invasion for stage IA1 and IA2 cervical cancer
Background Data regarding the prognostic significance of lymphovascular space invasion (LVSI) for stage IA1 and IA2 cervical cancer are limited. Specifically, the role of LVSI as an independent risk factor for mortality in stage IA disease has not been shown. Objective We examined the association between LVSI and nodal metastases and survival for women with stage IA1 and IA2 cervical cancer. Study Design We used the National Cancer Database to identify patients with stage IA adenocarcinoma or squamous carcinoma of the cervix from January 2010 through December 2015 for whom LVSI status was known. Mixed-effect log-Poisson models were used to identify predictors of LVSI. Cox proportional hazard models and Kaplan-Meier curves were used to compare all-cause mortality. Results We identified 3239 patients with stage IA1 and 1049 patients with stage IA2 carcinoma of the cervix. Among patients with stage IA1 and IA2 disease, 10.5% and 18.8% had LVSI, respectively. Less than 1% of patients with stage IA1 disease without LVSI had positive nodes compared with 7.8% of those with LVSI (pConclusions LVSI is associated with lymph node metastases in patients with stage IA cervical cancer. LVSI is associated with decreased survival for women with stage IA2 cervical cancer.
- 1 March 2020
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 222 (3) , S792-S793
30: Preoperative evaluation with MRI and LDH testing in patients undergoing intra-abdominal surgery for fibroids: Effect on surgical route
- 1 March 2020
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 222 (3) , S792-S793
30: Preoperative evaluation with MRI and LDH testing in patients undergoing intra-abdominal surgery for fibroids: Effect on surgical route
- 1 December 2019
- Published by SAGE Publications in Journal of Gynecologic Surgery
- Vol. 35 (6) , 363-369
Magnetic Resonance Imaging to Rule out Leiomyosarcoma in Patients Undergoing Surgery for Leiomyomas: A Real World Experience in an Unenhanced Patient Population
Objective: Surgery for leiomyomas is common; yet, no reliable test can help distinguish a benign leiomyoma and malignant leiomyosarcoma (LMS). Materials and Methods: This retrospective observational cohort study evaluated patients before and after implementation of a protocol to identify LMS, which included magnetic resonance imaging (MRI) with diffusion-weighted imaging. Results: This study revealed the incidence of uterine pathology, as well as MRI, lactate dehydrogenase (LDH), and pathology results, in 1085 patients—479 before and 606 after implementation of the protocol. Two cases of LMS were identified in the postprotocol cohort, and 70% of the patients underwent MRI. Test statistics for MRI to detect LMS in this cohort were: sensitivity of 100%; specificity of 67%; positive predictive value of 1%; negative predictive value of 100%; false–positive rate of 33%; and false–negative rate of 0%. For patients with both MRI and LDH results (358/606, 59%), 56.7% had normal MRI and LDH, 9.8% had negative MRI but high LDH, 6.4% had abnormal MRI and high LDH, and 27.1% had abnormal MRI and normal LDH. Conclusion: Preoperative MRI for detecting LMS had high a sensitivity and a high false–positive rate, which warrants caution in interpreting MRI results, particularly in women of childbearing age.
- 1 December 2019
- Published by SAGE Publications in Journal of Gynecologic Surgery
- Vol. 35 (6) , 363-369
Magnetic Resonance Imaging to Rule out Leiomyosarcoma in Patients Undergoing Surgery for Leiomyomas: A Real World Experience in an Unenhanced Patient Population
Objective: Surgery for leiomyomas is common; yet, no reliable test can help distinguish a benign leiomyoma and malignant leiomyosarcoma (LMS). Materials and Methods: This retrospective observational cohort study evaluated patients before and after implementation of a protocol to identify LMS, which included magnetic resonance imaging (MRI) with diffusion-weighted imaging. Results: This study revealed the incidence of uterine pathology, as well as MRI, lactate dehydrogenase (LDH), and pathology results, in 1085 patients—479 before and 606 after implementation of the protocol. Two cases of LMS were identified in the postprotocol cohort, and 70% of the patients underwent MRI. Test statistics for MRI to detect LMS in this cohort were: sensitivity of 100%; specificity of 67%; positive predictive value of 1%; negative predictive value of 100%; false–positive rate of 33%; and false–negative rate of 0%. For patients with both MRI and LDH results (358/606, 59%), 56.7% had normal MRI and LDH, 9.8% had negative MRI but high LDH, 6.4% had abnormal MRI and high LDH, and 27.1% had abnormal MRI and normal LDH. Conclusion: Preoperative MRI for detecting LMS had high a sensitivity and a high false–positive rate, which warrants caution in interpreting MRI results, particularly in women of childbearing age.